Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Cardiology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Under the Lens: Progression of Diabetic Retinopathy and the Impact of Fenofibrate
October 2024
With an increasing prevalence of diabetic retinopathy, a cause of vision impairment and blindness in those with diabetes, there is a need…
Read more
17th October 2013
New Insights into the Definitive Management of Venous Thromboembolism
This educational symposium, supported by an unrestricted educational grant from Daiichi Sankyo, was given at the European Society of Cardiology (ESC)…
17th October 2013
Ace-Inhibitors and Cardioprotection Open Issues and Future Solutions
The current management of patients with hypertension, especially those with a high risk of coronary artery disease should take into account the role of…
17th October 2013
The Changing Landscape in Oral Anticoagulation - The Last Pieces of the Puzzle
Dabigatran, rivaroxaban, apixaban and edoxaban are four new oral anticoagulants (NOACs). There are an increasing number of indications for which these…
17th October 2013
Practical Guidance for Stroke Prevention in Atrial Fibrillation – Interactive Case Studies
This Boehringer Ingelheim sponsored satellite symposium was held on 2nd September 2013 as part of the ESC conference, which was hosted this year in…
17th October 2013
Managing Thromboembolic Risks of Atrial Fibrillation: Can We Afford Increased Efficacy of the Novel Anticoagulants and Devices?
Ischaemic/embolic complications are the most common severe consequences of atrial fibrillation. Although chronic anticoagulation with warfarin has been…
17th October 2013
Atrial Fibrillation in Childhood with Familial Hyperthyroidism in Afro-Caribbeans
Atrial fibrillation (AF) associated with familial hyperthyroidism (FH) spanning three generations concomitantly, is rare. The index case was 10 years old…
17th October 2013
Consistency Versus Equity – Cardiovascular Disease Management For South Asians in the United Kingdom
An increased risk of coronary heart disease was an immediate healthcare concern following the mass arrival of South Asian immigrants to the UK, and it…
17th October 2013
Prescribing Physical Activity for the Prevention and Treatment of Hypertension in Patients with Aortic Coarctation - A Review
Patients who have been treated for aortic coarctation (CoA) have increased late cardiovascular morbidity and mortality, which is partly due to the…
Loading posts...
« Previous
1
…
21
22
23
24
Next »